Urgent Safety Alert: Generic Cetirizine Medication Recalled Across the U.S.
If you rely on cetirizine to manage your seasonal allergies, you need to pay close attention to your medication bottle. The U.S. Food and Drug Administration (FDA) has issued a recall for a generic version of the popular allergy medication Zyrtec due to a serious contamination risk.
The recall involves antihistamine drugs produced by Unique Pharmaceutical Laboratories. These medications, specifically cetirizine hydrochloride tablets USP 5 mg, are being voluntarily pulled from the market after reports of potential cross-contamination with ranitidine, a drug typically used to treat heartburn.
How the Contamination Was Discovered
The issue came to light when a vigilant pharmacy technician noticed unusual physical characteristics while counting and bottling the tablets. The warning signs included:
- n
- Red dots appearing on some of the cetirizine tablets.
- General discoloration of the medication.
Why This Is a Health Risk
While cetirizine is a staple for allergy relief, the presence of ranitidine can be dangerous for certain individuals. The FDA warns that consumers who are hypersensitive to the ingredients in ranitidine could experience severe, life-threatening adverse reactions, including:
- n
- Hypotension (dangerously low blood pressure).
- Shortness of breath and difficulty swallowing.
- Loss of consciousness.
Fortunately, as of the latest reports, there have been no reported adverse events related to this specific recall, but the precaution is critical to prevent future emergencies.
Are Your Tablets Affected?
The affected products were distributed by Rising Pharma Holdings Inc. to various retailers across the United States. Here are the key details to check on your packaging:
- n
- Product: Cetirizine hydrochloride tablets USP 5 mg.
- Packaging: 100-tablet bottles.
- Expiration Date: October 2028.
What Should You Do Now?
If you have these medications in your home, do not panic, but take immediate action:
- Stop using the medication if you notice any discoloration or red spots on the tablets.
- Contact the distributor: Reach out to Rising Pharma Holdings Inc. at 1-844-874-7464 or via email at pv@risingpharma.com or qa@risingpharma.com for return arrangements.
- Consult your doctor: If you have already taken the medication and feel unwell, contact your healthcare provider immediately.
Staying informed about drug recalls is essential for your safety. For more updates on medication safety and health alerts, keep an eye on official FDA communications.
